Ando, Apigyn P.

HRN: 07-94-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
MUPIROCIN 2%, 15G (TUBE)
04/29/2022
05/06/2022
PER DERMAL
0.1g
BID
Post-op Wound Prophylaxis
Waiting Final Action 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes